PEREGRINE PHARMACEUTICALS Stock Price
$1.47 
Change:
-0.05 -1.64% Volume:
34,035
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 1.52 | Todays Low: 1.46 | Open: 1.52 | Last Close: 1.505
52 Wk High: 5.5 | 52 Wk Low: 0.47 | Todays Pivot: 1.48 | Pre market open: 1.79
Sector: 
Online News For Peregrine Pharmaceuticals
|
Has Peregrine Pharmaceuticals Finally Turned The Corner? - Seeking Alpha
Wed, 12 Jun 2013 20:49Peregrine Pharmaceuticals, Inc (PPHM) is a clinical stage biopharmaceutical company that is focused on the treatment of cancer. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc ...
|
|
Why Peregrine Pharmaceuticals Shares Popped - DailyFinance
Tue, 04 Jun 2013 08:41Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Peregrine Pharmaceuticals , a biopharmaceutical ...
|
|
Encouraging News for Peregrine Pharma - Analyst Blog - NASDAQ
Fri, 24 May 2013 16:37Peregrine Pharmaceuticals ( PPHM ) recently received encouraging news when the company announced that the US Food and Drug Administration (FDA) has agreed on the design for the phase III registration trial for its oncology candidate, bavituximab.
|
|
Hot Stocks in Focus: Generex Biotechnology Corporation, Westinghouse Solar ... - Openglobe
Mon, 03 Jun 2013 15:39Peregrine Pharmaceuticals (NASDAQ:PPHM) shares gained 9.42% to $1.80. The company, on May 20, announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Phase III registration trial design of the company's lead ...
|
|
Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of ... - Seeking Alpha
Thu, 23 May 2013 21:50Bavituximab is a phosphatidylserine (PS) binding monoclonal antibody (MAB) produced by Peregrine Pharmaceuticals (PPHM), which appears to be "The Golden Goose" when it comes to Immunotherapy approaches to fighting solid tumor cancers.
|
|
Stocks to Watch (UniPixel Inc, Real Goods Solar, Peregrine Pharmaceuticals ... - SBWire (press release)
Wed, 22 May 2013 13:17Peregrine Pharmaceuticals (NASDAQ:PPHM) shares declined 9.29% to $1.66. The company, on May 20, announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Phase III registration trial design of the company's lead ...
|
PPHM Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Peregrine Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for PPHM to choose from. Visit here to build your stock quote widget »
